In class this week we discussed the types of biomaterials that can be used tissue engineering and recent advancements in the field. There appears to be little published research that examines the use of tissue engineering to deliver contraceptive drugs. As a result, I examined how tissue engineering has been used in women’s reproductive health. I found that female reproductive tissue is an interesting application for tissue engineering because properties of the tissues may change due to the menstrual cycle and due to puberty, pregnancy, and menopause. As a result, finding biomaterials that can mimic the biological function of tissue is essential for creating effective solutions. Women suffering from reproductive organ failure due to acquired disorders, congenital defects, or trauma have few options currently besides surgical transplantation. Reproductive organ failure may cause infertility and loss of function.
In the article, “Efficient Biomaterials for Tissue Engineering of Female Reproductive Organs”, the authors review current biomaterials that are being investigated to create female reproductive tissues and reproductive organs. Restoring normal function of reproductive organs is extremely challenging because the bioengineering materials must restore structure and function, including the excretion of hormones.
One of the applications for tissue engineering was in the construction of ovaries. Ovaries store oocytes and secrete reproductive hormones, including estrogen, testosterone, and progesterone. The endocrine function of the ovaries involves complex signaling between follicles and their environment, which relies on mechanical signaling with the ECM and endocrine and paracrine signaling pathways. The signals begin folliculogenesis, which causes the reproductive cycle. Current techniques for treating dysfunctional ovaries include hormone therapy, uterine auto-transplantation and xeno-transplantation, ex-vivo fertilization, and, as discussed in the review, the development of artificial ovaries. Ovaries could be constructed by applying scaffolds with necessary cells and pharmaceutical agents. Scaffolds may be made with natural or synthetic materials, both of which were discussed in the article.
Creating biomaterials that can mimic the ovaries ECM is critical for restoring the complex signaling and interactions that occur with the human follicles. The ECM in ovarian tissue contains proteins such as collagen and glycoproteins such as fibronectin and lamin. During follicular development, the amount of and location of fibronectin and laminin. In order to create an artificial ovary, biomaterials must support the growth and attachment of follicles and ovarian stromal cells to the ECM. The biomaterial must mimic the ovarian tissue in order to maintain biological signals and mechanical strength. Currently natural materials being used in tissue engineering include alginate, fibrin, collagen, gelatin and hyaluronic acid and synthetic materials such as silica, polyethylene glycol, and polydimethylsiloxane. As we’ve learned in class, natural materials can be beneficial because they are more similar to the human ECM and have greater biocompatibility and bioactivity than synthetic polymers, which can be toxic when degraded in the body.
The review discusses the advantages and disadvantages of each of the materials that have been investigated for this application. They first identify five ideal properties: biocompatibility, degradation kinetics (ie allow growth of ovarian follicles), degradation by productions not toxic, mechanical properties, and biomimicry.
Alginate is a polysaccharide derived from algae that can form a hydrophilic and biocompatible stable matrix that can handle isolated follicles. Alginate combined with ascorbic acid has been shown to improve the survival of mouse follicles and in vitro tests demonstrated vascularization and low inflammation.
Fibrin is another popularly studied biomaterial for ovaries. Fibrin matrixes encapsulated ovarian mice follicles and then transplanted into the mice. After a week, angiogenesis and follicular development had occurred. Fibrin can be degraded, so researchers have examined a matrix made of fibrin and alginate because alginate is not degradable. The combination matrices were used for the ovarian cells and showed more dynamic mechanical properties.
The article also discusses research that’s been done to create a decelluarized ovary. The the ECM of the ovary can then be reseeded with ovarian cells. Recellularized ovaries with reseeded with ovarian cell where able to initiate puberty in in vivo mice studies. In conclusion, extensive work is still required before engineered ovaries will be able to be used in humans. Most likely a combination of biomaterials will have to be utilized in order to create the unique structure found in ovaries.
Source: Tamadon, A., et al. Efficient biomaterials for tissue engineering of female reproductive organs. Tissue Eng. Regener. Med. 13(5):447–454, 2016.